Evidence map›Paper›PMID 41016049›Full record

ArticlePlant biology (Stuttgart, Germany)2026

Phenolic compounds in species of the Blechnaceae.

M Ufland, M Petersen

Abstract read
In one paragraph

Article in Plant biology (Stuttgart, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M UflandInstitut für Pharmazeutische Biologie und Biotechnologie, Philipps-Universität Marburg, Marburg, Germany.
M PetersenInstitut für Pharmazeutische Biologie und Biotechnologie, Philipps-Universität Marburg, Marburg, Germany.ORCID https://orcid.org/0000-0001-7769-8556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosmarinic acid and other caffeic and 4-coumaric acid derivatives are widespread in land plants. These phenolic compounds contribute to the medicinal uses of plants. Ferns (Polypodiopsida), however, are still under-investigated in terms of phenolic natural products and their biosyntheses. We analysed 32 fern species in the Blechnaceae, encompassing all three subfamilies, for content of caffeoyl-5-O-quinic acid, rosmarinic acid and related compounds using LC/ESI-MS/MS and HPLC. A compound previously unknown from ferns, but known in two species of Lamiaceae, was purified, its structure elucidated by NMR, and named blechnic acid B. While caffeoyl-5-O-quinic acid was present in extracts from all investigated species, rosmarinic acid was only found in four species (Doodia maxima, Lomariocycas tabularis, Neoblechnum brasiliense, Oceaniopteris ciliata) belonging to superclade B of the Blechnoideae subfamily. Blechnic acid B, a novel compound in ferns, is composed of two moieties of isorinic acid (caffeoyl-4'-hydroxyphenyllactic acid). This lignan was only detected in Neoblechnum brasiliense, together with three related lignans having one or two 3,4-dihydroxyphenyllactic acid moieties. Our study suggests that genes for biosynthesis of caffeoyl-5-O-quinic acid were already established in ancestor species of the Blechnaceae. Blechnic acid B and its three derivatives might have formed through a selective coupling of the rosmarinic/isorinic acid monomers with the help of a dirigent protein.

Indexed as

FernsPhenolsCaffeic AcidsChromatography, High Pressure LiquidCinnamatesDepsidesPlant ExtractsQuinic AcidRosmarinic AcidTandem Mass SpectrometryCaffeic AcidsCinnamatesDepsidesPhenolsPlant ExtractsQuinic AcidRosmarinic AcidBlechnic acid Bcaffeoyl‐5‐O‐quinic acidphenolic compoundsrosmarinic acid

Identifiers

PMID41016049
PMCPMC12710811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.